Sol-Gel Technologies (SLGL) Revenue (2018 - 2026)
Sol-Gel Technologies (SLGL) posted quarterly Revenue of $108000.0 for Q1 2026, down 89.52% year-over-year from $1.0 million in Q1 2025, and down 84.48% quarter-over-quarter from $696000.0 in Q4 2025.
Sol-Gel Technologies (SLGL) Revenue (2018 - 2026) Analysis & Trends
Sol-Gel Technologies (SLGL) has reported Revenue for 9 consecutive years, with $108000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Revenue fell 89.52% year-over-year to $108000.0; the TTM figure through Mar 2026 stood at $18.5 million (up 52.57% YoY), while the FY2025 annual figure was $19.4 million, up 68.04% from the prior year.
- Revenue declined to $108000.0 in Q1 2026 per SLGL's latest filing, from $696000.0 in the prior quarter.
- Across five years, Revenue topped out at $3.0 billion in Q1 2022 and bottomed at $100000.0 in Q4 2022.
- Historically, Revenue has averaged $202.4 million across 5 years, with a median of $594000.0 in 2023.
- On a YoY basis, Revenue climbed as much as 427860.06% in 2022 and fell as far as 99.52% in 2022.
- Sol-Gel Technologies' Revenue stood at $100000.0 in 2022, then soared by 347.0% to $447000.0 in 2023, then sank by 37.81% to $278000.0 in 2024, then soared by 150.36% to $696000.0 in 2025, then slumped by 84.48% to $108000.0 in 2026.
- Business Quant data shows SLGL's Revenue at $108000.0 in Q1 2026, $696000.0 in Q4 2025, and $400000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Sol-Gel Technologies | 240.26 Mn | 230.12 Mn | - | 108,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 108,000.00 |
| Dec 31, 2025 | 696,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 17.26 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 278,000.00 |
| Sep 30, 2024 | 5.36 Mn |
| Jun 30, 2024 | 5.43 Mn |
| Dec 31, 2023 | 447,000.00 |
| Sep 30, 2023 | 213,000.00 |
| Jun 30, 2023 | 594,000.00 |
| Dec 31, 2022 | 100,000.00 |
| Sep 30, 2022 | 261,000.00 |
| Jun 30, 2022 | 3.52 Mn |
| Mar 31, 2022 | 3.00 Bn |
| Dec 31, 2021 | 20.81 Mn |
| Sep 30, 2021 | 1.34 Mn |
| Jun 30, 2021 | 928,000.00 |
| Mar 31, 2021 | 701,000.00 |
| Dec 31, 2020 | 2.06 Mn |